Poland· PL-100483661
Granmesa
A mesalazine product containing mesalazinum, registered in Poland by Recordati Polska Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mesalazine is registered in 17 of 19 countries.
Countries holding a registration under ATC A07EC02 (mesalazine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Mesalazine · ATC A07EC02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mesalazine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.00 in Italy to $2.13 in Switzerland — a ×2.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mesalazine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.13
- FR France$1.06
- IT Italy$1.00
The record
At a glance
URPL (Poland)- Active substance
- Mesalazinum
- Manufacturer
- Recordati Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A07EC02
- ATC class
- Mesalazine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991586300
- gtin05909991586317
- gtin05909991586324
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
333 interactions on record for mesalazine.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mesalazine · interactions on record
333 records
- 15 severe
- 95 moderate
- 223 info
Most severe, free to view
- CidofovirJ05AB12severe
- Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
- Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
- SirolimusL01EG04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mesalazine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsPentasa Compact 1 g, granulaat met verlengde afgifteBModesto B.V.
- SwedenPentasa Sachet 1 g DepotgranulatFerring Läkemedel AB
- CzechiaSALOFALKDr. Falk Pharma GmbH, Freiburg
- IrelandPentasa Sachet 1g prolonged-release granulesPCO Manufacturing Ltd.
- SwitzerlandSalofalk 1000 mg, GranulatDr. Falk Pharma AG
- FranceOSPERZO 1000 mg, granulés à libération prolongéeFALK PHARMA
- BelgiumColitofalk 1000 mgDr. Falk Pharma
- FinlandPentasaFerring Lääkkeet Oy
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Azzavix, Claversal
- Belgium · Asamovon, Claversal
- Bulgaria · Salofalk – Салофалк, Пентаза
- Cyprus · Asacol, Mecolzine
- Czechia · Asacol, Asacol Enema
- Germany · Asacol, Claversal
- Denmark · Asacol, Mesalazin Orion
- Estonia · Asacol, Pentasa
- Spain · Asacol, Azzavix
- Finland · Asacol, Asacol 1 G
- France · Fivasa, Mazalvix
- United Kingdom (Northern Ireland) · Asacol, Mesalazine
- Greece · Asacol, Asalazin
- Croatia · Pentasa, Salofalk
- Hungary · Pentasa, Salofalk
- Ireland · Asacolon, Galtasa
- Iceland · Asacol, Pentasa
- Italy · Argonal, Asacol
- Lithuania · Asacol, Pentasa
- Luxembourg · Claversal, Claversal Foam
- Latvia · Asacol, Pentasa
- Malta · Mecolzine, Mezavant Xl
- Netherlands · Asacol, Azzavix
- Norway · Asacol, Mesalazin Orion
- Portugal · Asacol, Azzavix
- Romania · Mesalazina Alfasigma, Pentasa
- Sweden · Asacol, Mesalazin Orion
- Slovenia · Asacol, Asacol®
- Slovakia · Pentasa, Pentasa Sachet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccc55a75-ab43-475d-b58a-93a9b6225b94 GET /v1/drugs/ccc55a75-ab43-475d-b58a-93a9b6225b94?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat o przedłużonym uwalnianiu, w saszetce",
"source": "urpl",
"strength": "1 g",
"packaging": "05909991586300 ¦ Rp ¦ 163032\n50 sasz. 1 g\n05909991586317 ¦ Rp ¦ 163033\n100 sasz. 1 g\n05909991586324 ¦ Rp ¦ 163034\n150 sasz. 1 g",
"substance": "Mesalazinum 1000 mg",
"common_name": "Mesalazinum",
"pl_product_id": "100483661",
"pozwolenie_nr": "29293",
"auth_procedure": "NAR",
"authorisation_validity": "2030-10-15"
}See everything about mesalazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.